Member Login
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

AstraZeneca PLC (LSE: AZN) Latest News

Investing Articles

AstraZeneca stock: time to sell?

| Pam Narang

Looking beyond the company’s vaccine woes, is now the time to make the most of the uptick in AstraZeneca stock…

Read more »

Investing Articles

The AstraZeneca share price is rising fast. Here’s what I’d do now

| Manika Premsingh

The AstraZeneca share price is rising fast after its robust results. But can it rise much further from its already…

Read more »

Windmills for electric power production.
Investing Articles

ESG investing: which UK companies might I invest in?

| Andy Ross

A look at ESG investing and two UK FTSE 100 companies with strong ESG credentials, which might make them appealing…

Read more »

Investing Articles

Novacyt or AstraZeneca: which biotech stock should I buy?

| Kirsteen Mackay

Novacyt and AstraZeneca are two biotech stocks working in the realms of fighting the Covid-19 pandemic. Are either good long-term…

Read more »

Scientist filling a needle
Investing Articles

3 reasons to buy the FTSE 100’s AstraZeneca stock now

| Kevin Godbold

Here's why I'd be keen to get a solid-looking business such as AstraZeneca into my long-term diversified portfolio right now.

Read more »

Syringe and vial on blue background
Investing Articles

Is the AstraZeneca share price undervalued?

| Roland Head

The AstraZeneca share price has been falling since last summer. Roland Head is starting to see a potential buying opportunity.

Read more »

Syringe and vial on blue background
Investing Articles

As the AstraZeneca share price slides, I’d buy

| Rupert Hargreaves

The AstraZeneca share price has been under pressure due to temporary headwinds, but these will not last forever and growth…

Read more »

Investing Articles

2 unloved FTSE 100 stocks I’d buy before it’s too late

| Ben Hargreaves

With the FTSE 100 rising recently, one Fool looks at two companies that have been left behind and why this…

Read more »

Investing Articles

These are 2 of my top stocks to buy in April 

| Manika Premsingh

These are Manika Premsingh's two top stocks because of their strong credentials combined with their current subdued share prices.

Read more »

Investing Articles

Best stocks to buy: my money’s on AstraZeneca shares

| Rupert Hargreaves

In my basket of the best stocks to buy now, AstraZeneca shares feature prominently, considering the company's long-term outlook.

Read more »

Syringe and vial on blue background
Investing Articles

The AstraZeneca share price steadies: is this FTSE 100 stock a good investment?

| Kirsteen Mackay

The AstraZeneca share price is showing resilience in the face of disappointing vaccine publicity. This FTSE 100 stock has a…

Read more »

positive mental health woman
Investing Articles

2 FTSE 100 shares to buy right now

| Rupert Hargreaves

Rupert Hargreaves takes a look at a couple of his favourite FTSE 100 stocks he believes could be among the…

Read more »